logo
How video games are reshaping global health: ADHD, mental health

How video games are reshaping global health: ADHD, mental health

Forbes13-04-2025

Children playing games on mobile phones, France. (Photo by: Godong/Universal Images Group via Getty ... More Images)
Research and expert insights illustrate how gamified health tools are creating behavior change in public health worldwide.
Can a video game ease anxiety, build focus, or support a child with ADHD?
As healthcare challenges surge globally — especially among youth — innovators are turning to an unlikely tool: video games. Now one of the world's largest entertainment industries, the global gaming market is projected to surpass $522 billion by the end of 2025, according to Statista. A new wave of purpose-driven games has emerged to promote emotional well-being, treat attention disorders, and teach life-saving health behaviors. A landmark NIH study found mental health video games improved 69% of psychological therapy outcomes — a breakthrough that's shifting perceptions of what games can do. From ADHD awareness games backed by top psychologists to vaccine education games supported by WHO, these aren't just games — they're evidence-based digital health tools reshaping public health communication. My new video interview with WHO's Andy Pattison supports this thesis.
From Play to Purpose: How ADHD Awareness Games and Gamified Health Tools Drive Global Behavior Change
According to Psyon Games CEO Olli Rundgren, 'The combined impact of gamified health interventions could result in a 10–30X increase in efficiency compared to traditional awareness methods, through enhanced engagement, improved knowledge retention, improved longevity and stronger behavioral outcomes.'
One standout example is FULL ADHD, a purpose-driven awareness game developed by Psyon Games in partnership with Takeda Pharmaceuticals. In Finland, the game saw user engagement average 17 minutes per session — nearly 8 times longer than typical health website visits. The game also achieved 82% lower cost-per-install than industry benchmarks, with 88% of players reporting a changed perception of ADHD. Psyon is also finalizing a feasibility study for an HPV awareness game backed by the Gates Foundation in Africa - — part of a growing wave of purpose-driven games reshaping global health communication.
Breaking the Stigma and Building Empathy
Stephen V. Faraone, PhD, Distinguished Professor at SUNY Upstate Medical University, believes that digital ADHD awareness tools can play a pivotal role in public education. 'We live in a world where many people do not understand mental disorders, especially those that affect children. That leads to stigma, bullying and being ostracized,' he says. He views ADHD awareness games as scalable tools to improve empathy and tolerance, especially in regions where diagnosis and understanding are limited.
Games' immersive storytelling offers more than awareness — they create emotional resonance and foster behavior change. Faraone emphasizes that campaigns rooted in storytelling may shift public perception more effectively than traditional formats.
The Design Secret: Aligning Motivation and Context
According to Andreas Lieberoth, PhD, Associate Professor at the Danish Institute of Education, mental health video games are most effective when timed with user motivation. 'The best health games don't just entertain — they scaffold behavior change,' he says. 'They work well when they activate and enhance situations where people already want help or need a nudge to start.'
He emphasizes good design over gimmicks: short-term appeal through gamelike aesthetics can spark interest, but long-term engagement requires alignment with the user's needs and context. Mobile games excel during 'digital snacking' moments, but only if they deliver timely, realistic challenges and feedback.
Lieberoth advocates embedding gamification in education platforms, therapy tools, or work utilities as cognitive support. 'Gamification works best when it supports systems people already use.'
Why Games Work: From Passive Learning to Active Transformation
Rachel Mutuku, Global Director at Girl Effect, has seen purpose-driven games transform health engagement across India, Kenya, and Tanzania. 'Instead of being told what to do, girls made choices, faced outcomes, and learned through doing,' she says. In India, their Go Nisha Go mobile game let players step into the life of a 19-year-old navigating reproductive health, building empathy through role-play.
Gamification in education also enabled sustained engagement. In the past year, over 100,000 youth interacted with Girl Effect's chatbots and IVR-based choose-your-adventure games. A partnership with Wysa introduced AI-powered health chatbots into Girl Effect's tools, offering anxiety relief and well-being support.
Mutuku says games break taboos in conservative regions, support personalization at scale, and enable continuous learning. In areas where traditional healthcare is inaccessible or mistrusted, health games for youth are transformative.
Siff Malue Nielsen at WHO Europe backs this with data. In a study of more than a thousand students, those who played WHO's Immune Patrol game outperformed peers taught through traditional methods. The gamified modules used narrative-driven sandbox challenges to teach immunization concepts and promote vaccine confidence.
'Students recognized the importance of learning about immunization,' Nielsen says. 'And teachers saw faster vocabulary growth and deeper understanding.'
She emphasizes cultural sensitivity, noting that success varies by region. 'We must consider the when, where, and who — tailoring content to specific communities is essential to drive behavioral health engagement.'
Katrine Habersaat, who leads the WHO Regional Office's Behavioral and Cultural Insights Unit, agrees that gamification can equip children with lifelong critical thinking and health literacy skills. 'Games like Immune Patrol don't just inform — they help children navigate misinformation,' she explains. Embedding such tools into school curricula can create ripple effects, even shaping caregivers' health choices.
From ADHD to Global Health: The Power of Narrative and Personalization
Karolien Poels, Professor of Strategic Communication at the University of Antwerp, highlights transparency and co-design as pillars of trust. 'Let students know what the game is about. Involve parents and teachers. And match the quality of commercial games kids play,' she says.
Her research confirms that emotional connection through avatars and immersive storylines deepens learning. Serious games must offer high production value, she adds, especially if used outside of school.
Poels recommends defining goals clearly and involving the end user throughout. 'If the game is to work long-term, it has to be fun, evidence-based, and easily accessible — with the right distribution channels.'
Future Vision: Smarter Tools, Higher Impact
As the space grows, experts emphasize sustainability. Lieberoth cautions against shallow gamified layers like badges or leaderboards unless supported by deep design thinking. He advocates for embedding games into trusted platforms where they act as ongoing cognitive scaffolds.
Olli Rundgren agrees. 'We've shown strong impact with modest budgets,' he says, 'but there's untapped potential in deeper storytelling, better design, and more immersive experiences.'
He also sees potential in combining purpose-driven games with AI-powered health chatbots. 'Imagine blending a game's emotional arc with real-time adaptive support — that's where we're headed.'
Let the Games Begin
Health games for youth are no longer niche experiments. They are cost-effective, emotionally engaging, and scientifically validated tools for reshaping healthcare communication. When grounded in empathy, research, and cultural awareness, they don't just raise awareness — they change lives.
As Rundgren says, 'When you create something that people love to use, it doesn't just raise awareness — it drives real behavioral health engagement.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Map Shows States With Highest Levels of Tiny, Toxic Air Pollution
Map Shows States With Highest Levels of Tiny, Toxic Air Pollution

Newsweek

time3 hours ago

  • Newsweek

Map Shows States With Highest Levels of Tiny, Toxic Air Pollution

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. California and Oregon are among the U.S. hotspots for dangerous submicron (PM1) air pollution—those with particles less than a micron, or a millionth of a meter wide—according to new research. Researchers at Washington University of St. Louis have been quantifying the amount of submicron particles in the air across the country over the last 25 years. The data, which calculated submicron estimates based on known rations of what makes up PM 2.5 particles (those less than 2.5 microns wide), suggest that many areas in the east of the contiguous U.S. contain hotspots. Because PM1 pollution is much smaller than PM2.5 (and at least six times smaller than human blood cells), it has the potential to lead to even worse health effects, as it is small enough to slip past the body's defenses. Parts of Arizona, California, Idaho, New Mexico, Oregon and Texas all appear to have higher concentrations of submicron particulate matter, shown by darker red areas on the researchers' map, as below. A map of the U.S. showing the concentration of submicron particulate matter, with higher concentrations shown by darker red areas. A map of the U.S. showing the concentration of submicron particulate matter, with higher concentrations shown by darker red areas. Atmospheric Composition Analysis Group Conversely, parts of Colorado, Montana, Utah, and Wyoming appear to have far fewer dark patches on the map, suggesting much lower levels of submicron particulate matter. Parts of Arizona and New Mexico showed high concentration levels in some areas, and much lower levels among other regions of their respective state. Higher concentrations of PM1 were found in major urban and industrial areas and areas affected by wildfires, highlighting the role of combustion sources in producing harmful particles. This contrasts with lower concentrations being prevalent across the arid west. The World Health Organization (WHO) suggests that 99 percent of the global population breathes in air containing high levels of pollutants and exceeds the WHO guidelines. The combined effects of ambient air pollution with household air pollution are associated with 7 million premature deaths every year. Both outdoor and indoor air pollution can cause respiratory diseases, as the small particles are able to get deep into the lungs or potentially even into the bloodstream. Exposure to particle pollution can cause heart attacks, irregular heartbeat, aggravated asthma, decreased lung function, and difficulty breathing, according to the Environmental Protection Agency. According to Chi Li, assistant research professor and first author of the study, the small particles identified tend to come from direct air emissions, such as black carbon particles from diesel engines, or the smoke from wildfires. PM1 can also form through secondary processes however, when sulfur dioxide or nitrogen oxides are spit out through fuel combustion and burning coal, Li noted. The significance of pollution regulation should not be overlooked, as the dataset reveals that PM1 levels dropped sharply from 1998 to 2022, as a result of regulations such as the Clean Air Act of 1970. Newsweek has contacted Li via email for comment. Do you have a tip on a science story that Newsweek should be covering? Do you have a question about air pollution? Let us know via science@ Reference Li, C., Martin, R. V., Donkelaar, A. van, Jimenez, J. L., Zhang, Q., Turner, J. R., Liu, X., Rowe, M., Meng, J., Yu, W., & Thurston, G. D. (2025). Estimates of submicron particulate matter (PM1) concentrations for 1998–2022 across the contiguous USA: Leveraging measurements of PM1 with nationwide PM2·5 component data. The Lancet Planetary Health, 9(6).

Supernus makes depression drug play with $795m Sage buyout
Supernus makes depression drug play with $795m Sage buyout

Yahoo

time3 hours ago

  • Yahoo

Supernus makes depression drug play with $795m Sage buyout

Fewer than five months after rejecting a takeover approach by Biogen, Sage Therapeutics has found a buyer in Supernus Pharmaceuticals. According to the deal, Supernus will pay up to $795m to acquire depression treatment specialist Sage. The contract value significantly eclipses the $469m offered by Biogen in January 2025, a proposal that was swiftly rejected by Sage. The transaction has been approved by the boards of directors of both US-headquartered companies and is expected to close in Q3 2025. Share price in Sage surged 26% at market open in the US following the announcement on 16 June while Supernus shares opened 1% higher. In a statement, the two biotechs said that Sage is a 'strong fit with existing Supernus infrastructure'. Supernus has approved products in the US to treat Parkinson's disease and attention deficit hyperactivity disorder (ADHD), among others. Supernus is acquiring all shares of Sage for a price of $8.50 each, totalling an initial $561m. An additional $3.50 per share will be added to the deal depending on sales and commercial milestones for Sage's flagship product Zurzuvae (zuranolone), giving a potential deal value of $795m. Zurzuvae, whose ownership rights will now transfer to Supernus, is the only US Food and Drug Administration (FDA)-approved pill to treat postpartum depression. The acquisition affords Supernus a dominant position in the market. Co-developed with Biogen, Zurzuvae earned Sage $36.1m in sales in 2024 and $13.8m in Q1 2025. Following a 2020 agreement, Biogen has the exclusive licence to develop and commercialise Zurzuvae outside the US, excluding Japan, Taiwan, and South Korea. Sage, and now Supernus, retains US rights. Analysis by Pharmaceutical Technology's parent company GlobalData forecasts US sales of the drug to reach $290m by 2031. Sage struggled late last year with a series of mid-stage clinical trial failures. The company laid off 55% of its R&D team as a result, prioritising the commercial launch of Zurzuvae instead. Supernus's CEO Jack Khattar said: '[The acquisition] augments our growth profile by adding a significant fourth growth product to our portfolio and further diversifies our sources of future growth. Zurzuvae aligns with our focus on acquiring novel value-enhancing and clinically differentiated medicines to treat central nervous system conditions.' 'We have a proven track record of strong commercial execution, and we look forward to building on Zurzuvae's US growth momentum and collaboration with Biogen, so that more women with postpartum depression can benefit from this novel treatment.' "Supernus makes depression drug play with $795m Sage buyout" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

Patient Temperature Monitoring Market worth US$3.85 billion by 2032 with 6.7% CAGR
Patient Temperature Monitoring Market worth US$3.85 billion by 2032 with 6.7% CAGR

Yahoo

time4 hours ago

  • Yahoo

Patient Temperature Monitoring Market worth US$3.85 billion by 2032 with 6.7% CAGR

DELRAY BEACH, Fla., June 16, 2025 /PRNewswire/ -- The global Patient Temperature Monitoring Market, valued at US$2.31 billion in 2024 stood at US$2.44 billion in 2025 and is projected to advance at a resilient CAGR of 6.7% from 2025 to 2032, culminating in a forecasted valuation of US$3.85 billion by the end of the period. The patient temperature monitoring market is experiencing substantial growth due to several pivotal factors. Key drivers include a burgeoning global population and an escalating incidence of infectious diseases. Furthermore, heightened awareness regarding the critical role of continuous temperature assessment is significantly influencing market dynamics. The increasing volume of surgical interventions also contributes to the rising demand for perioperative temperature monitoring solutions. Additionally, the market is bolstered by advancements in remote patient monitoring technologies within home healthcare environments. Several opportunities are emerging, particularly the intensified focus on enhancing healthcare infrastructure and the proliferation of digital health initiatives in developing economies. Integration of predictive analytics into vital sign monitoring systems represents another critical avenue for accelerating market expansion. Download PDF Brochure: Browse in-depth TOC on "Patient Temperature Monitoring Market" 577 - Tables57 - Figures471 - Pages By application, the patient temperature monitoring market is categorized based on application into pyrexia/fever, hypothermia, blood transfusion, anesthesia, and other applications. Notably, the pyrexia/fever segment held the largest share in 2024 and is anticipated to exhibit the highest growth rate throughout the forecast period. This trend is primarily driven by the elevated global incidence of infectious diseases and the pivotal role temperature monitoring plays in the early detection, diagnosis, and management of febrile illnesses. The surge in thermometer utilization within clinical environments and domestic settings, particularly during pandemics and seasonal outbreaks, has significantly heightened the demand for effective fever detection solutions. WHO reported 263 million cases of malaria and approximately 597,000 associated deaths in 2023, with 94% of cases concentrated in the African region. In contrast, the Centers for Disease Control and Prevention (CDC) documented 249 million malaria cases in 2022. These alarming statistics, highlighting fever as a critical diagnostic symptom, have catalyzed an increased deployment of digital and infrared thermometers in hospitals, outpatient facilities, and home care settings. By end user, the patient temperature monitoring market has been categorized by end user into various segments, including hospitals, home care settings, ambulatory care centers, urgent care centers, primary centers, and other end users. It is anticipated that hospitals commanded the largest market share in 2024, primarily due to their substantial patient intake, sophisticated infrastructure, and the routine implementation of temperature monitoring devices in critical areas such as emergency departments, intensive care units (ICUs), and surgical theatres. Hospitals depend on an array of temperature monitoring technologies to facilitate accurate diagnoses and manage perioperative care, solidifying their role as the principal environment for device deployment. The uptick in elective surgical procedures within public hospitals is further amplifying the demand for dependable patient temperature monitoring solutions. According to data from the Australian Institute of Health and Welfare (AIHW), public hospital admissions for elective surgeries hit a historic peak of 778,500 in 2023–24, reflecting a 5.8% increase from 735,500 in 2022–23. This rising surgical volume accentuates the criticality of robust temperature monitoring systems to ensure patient safety during the perioperative phase and mitigate the risk of complications, such as hypothermia, during hospitalization. By geography, the patient temperature monitoring market is categorized into five primary regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. As of 2024, North America has emerged as the predominant region in this market, primarily due to its sophisticated healthcare infrastructure and the rapid integration of novel medical technologies. Several factors contribute to this regional dominance, including heightened awareness surrounding early diagnosis, an increase in surgical procedures, and the growing prevalence of remote and continuous monitoring solutions. Additionally, the region's expanding geriatric demographic and the rising incidence of chronic conditions—often associated with symptoms such as fever, wounds, and cardiovascular events—further stimulate demand for temperature monitoring systems. Furthermore, the proliferation of surgical facilities is a significant driver, as is the presence of key industry players such as Cardinal Health, Baxter, and Helen of Troy in the North American market. Collectively, these elements are fostering robust growth in the patient temperature monitoring market within the US. Request Sample Pages : Prominent players in the patient temperature monitoring market include Koninklijke Philips N.V. (Netherlands), Cardinal Health (US), Baxter (Hill-Rom Holdings, Inc.) (US), Drägerwerk AG & Co. KGaA (Germany), Becton, Dickinson and Company (US), Omron Healthcare, Inc.(Japan), Masimo (US), Helen of Troy (US), Solventum (US), Terumo Corporation (Japan), Dongguan Actherm Medical Corp. (China), Hicks India (India), Microlife Corporation (Taiwan), Medtronic (Ireland), American Diagnostic Corporation (US), EASYTEM (South Korea), Thermomedics, Inc. (US), Cosinuss GmbH (Germany), A&D Company, Limited (US), Paul Hartmann AG (Germany), Geratherm Medical AG (Germany), Exergen (US), OMEGA Engineering Inc. (US), DeltaTrak Inc. (US), Beurer GmbH (Germany), Nureca (India), iHealth Labs Inc. (US), Kinsa Inc. (US), and Medisana GmbH (Germany). Koninklijke Philips N.V. (Netherlands): Koninklijke Philips N.V. (Philips) is positioned as a dominant player in the patient temperature monitoring sector in 2024. The company's global footprint spans over 100 countries, including key markets such as the US, China, India, Japan, France, Canada, and South Africa. Philips operates approximately 38 manufacturing facilities across 26 countries, with significant hubs in the Netherlands, Germany, the US, China, Finland, Israel, and Brazil. Philips has executed a series of strategic initiatives to strengthen and expand its presence in the domain of patient temperature monitoring. A noteworthy development occurred in April 2024, when Philips announced a strategic partnership to integrate SmartQare's innovative monitoring solution, viQtor, with its established clinical patient monitoring platforms. This collaboration represents a substantial leap toward implementing next-generation continuous patient monitoring technologies in both hospital and home care settings, with an initial deployment targeted in Europe. In light of the rapidly advancing landscape of healthcare, Philips has markedly increased its focus on R&D efforts aimed at boosting product efficacy and differentiation, ensuring its offerings remain at the forefront of the market. Cardinal Health (US) Cardinal Health ranks as the second leading entity in the patient temperature monitoring sector, holding a substantial market share projected for 2024. As a prominent healthcare services and product provider, the company delivers tailored solutions to a diverse range of stakeholders, including hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician practices. The company boasts a robust international presence, particularly in North America, Europe, the Middle East, and Africa, underpinned by an extensive distribution network that spans key geographic markets such as the US, the UK, Switzerland, Sweden, Spain, the Netherlands, Italy, Germany, Ireland, Denmark, Croatia, Belgium, and France. Cardinal Health's competitive advantages stem from its strong geographic distribution capabilities, a technologically diverse and innovative product portfolio, and an established logistics framework. This strategic positioning allows the company to effectively address the diverse and evolving needs of healthcare providers across its operational territories. Baxter (Hill-Rom Holdings, Inc.) (US) Baxter (Hill-Rom Holdings, Inc.) has established itself as the third leading entity in the patient temperature monitoring market as of 2024. The company plays a critical role in this sector, capitalizing on its solid market presence, which is substantiated by strong sales performance and a comprehensive product portfolio that includes handheld, ear, and veterinary thermometers. Baxter's diverse array of offerings, paired with an extensive global distribution network, allows for effective penetration in various international markets. The company's geographical footprint includes a substantial presence in the US as well as other strategic regions. Its R&D capabilities are significant, with facilities located in the US, Germany, Singapore, Italy, and France. Furthermore, Baxter allocates a considerable portion of its revenue to R&D, fostering ongoing innovation and the development of advanced solutions tailored to the evolving needs of the patient temperature monitoring landscape. For more information, Inquire Now! Related Reports: Temperature Monitoring Systems Market Patient Monitoring Devices Market Brain Monitoring Market Veterinary Equipment and Supplies Market Wearable Healthcare Devices Market Get access to the latest updates on Patient Temperature Monitoring Companies and Patient Temperature Monitoring Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content to download multimedia: SOURCE MarketsandMarkets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store